Physician profile
James L Vermaelen
NPI 1467693440
$7,688.60
in general payments reported to CMS, 2019-2025
48 companies · $1,521 in 2025
The $1,521 reported for 2025 was more than what 83% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $543 · 2021: $192 · 2022: $1,390 · 2023: $1,746 · 2024: $1,321 · 2025: $1,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,533 · Travel and Lodging: $55.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,532.97 |
| Travel and Lodging | $55.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,278.17 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Genzyme Corporation | $815.44 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $626.15 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $571.34 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Regeneron Healthcare Solutions, INC. | $550.13 | 2019-2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $336.04 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $300.75 | 2019-2025 | Zerbaxa, Recarbrio, Dificid |
| E.R. Squibb & Sons, L.L.C. | $237.29 | 2019-2023 | |
| United Therapeutics Corporation | $203.84 | 2020-2025 | Tyvaso, Tyvaso |
| Ucb, INC. | $203.73 | 2020-2024 | Briviact |
| Inari Medical, INC. | $192.94 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Grifols USA, LLC | $177.37 | 2022-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $162.82 | 2020-2024 | Yupelri |
| Paratek Pharmaceuticals, INC. | $153.17 | 2020-2025 | Nuzyra |
| Pfizer INC. | $143.86 | 2021-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $136.30 | 2019-2023 | Kengreal, Cleviprex |
| Genentech USA, INC. | $124.83 | 2019 | |
| Penumbra, INC. | $119.01 | 2023 | Indigo System |
| Mallinckrodt Enterprises LLC | $109.65 | 2019 | |
| Insmed, INC. | $97.68 | 2019-2025 | Arikayce |
| Baxter Healthcare | $97.36 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Electromed, INC. | $88.54 | 2024-2025 | Smartvest |
| La Jolla Pharmaceutical Company | $68.28 | 2019-2024 | Giapreza |
| Inogen, INC. | $66.71 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Actelion Pharmaceuticals US, INC. | $60.58 | 2019-2023 | Uptravi, Opsumit |
| Viatris Specialty LLC | $59.14 | 2025 | Yupelri |
| Alexion Pharmaceuticals, INC. | $58.95 | 2022-2023 | Soliris |
| Portola Pharmaceuticals, LLC | $58.79 | 2019 | |
| Ani Pharmaceuticals, INC. | $52.48 | 2025 | Purified Cortrophin Gel |
| Abbvie INC. | $45.88 | 2025 | |
| Verona Pharma, INC. | $44.04 | 2025 | Ohtuvayre |
| Shionogi INC | $42.01 | 2024 | Fetroja |
| Edwards Lifesciences Corporation | $41.11 | 2019 | |
| Abiomed | $34.20 | 2023 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $34.14 | 2021-2023 | |
| Astellas Pharma US INC | $33.80 | 2019 | |
| Philips North America LLC | $30.89 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Pulmonx Corporation | $29.74 | 2025 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Vifor Pharma, INC. | $26.65 | 2024 | Veltassa |
| Biogen, INC. | $26.19 | 2019 | |
| Mallinckrodt Hospital Products INC. | $23.85 | 2022 | |
| Cardinal Health 200 LLC | $22.14 | 2021 | |
| Phadia US INC. | $21.19 | 2024 | Immunocap |
| Tanabe Pharma America, INC. | $20.20 | 2025 | Radicava |
| Novartis Pharmaceuticals Corporation | $18.24 | 2022 | |
| Scpharmaceuticals INC. | $17.83 | 2025 | |
| Cook Medical LLC | $16.26 | 2019 | |
| Ambu INC. | $8.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Vermaelen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.